SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 5,700 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.
Follow-Up Questions
SSY Group Ltd のCEOは誰ですか？
Mr. Jiguang Qu は SSY Group Ltd の Executive Chairman of the Board で、2005 から在籍しています。
LJUIF の株価パフォーマンスは？
LJUIF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
SSY Group Ltd の主な事業テーマや業界は？
SSY Group Ltd は Pharmaceuticals 業界、セクターは Health Care に属しています。
